Bio-Path Holdings Inc (BPTH)
2.31
-0.17
(-6.85%)
USD |
NASDAQ |
Jun 10, 16:00
2.29
-0.02
(-0.87%)
After-Hours: 20:00
Bio-Path Holdings Cash from Financing (Quarterly): 0.174M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.174M |
| December 31, 2023 | 0.514M |
| September 30, 2023 | 1.689M |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 1.734M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -0.003M |
| September 30, 2021 | 1.399M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 18.61M |
| December 31, 2020 | 4.289M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 7.289M |
| September 30, 2019 | 0.169M |
| June 30, 2019 | 0.045M |
| March 31, 2019 | 20.28M |
| December 31, 2018 | 0.001M |
| September 30, 2018 | 1.179M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 3.567M |
| September 30, 2017 | -0.03M |
| June 30, 2017 | 1.548M |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 9.007M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.4346M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 13.81M |
| December 31, 2013 | -0.0722M |
| September 30, 2013 | 2.887M |
| June 30, 2013 | 2.210M |
| March 31, 2013 | 0.3057M |
| December 31, 2012 | 0.6271M |
| September 30, 2012 | 0.7084M |
| June 30, 2012 | 0.2149M |
| March 31, 2012 | 0.0498M |
| December 31, 2011 | 0.5002M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.003M
Minimum
Dec 2021
18.61M
Maximum
Mar 2021
2.112M
Average
0.169M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Microbot Medical Inc | 2.397M |
| INVO Bioscience Inc | 0.5274M |
| Perspective Therapeutics Inc | 166.33M |
| EyePoint Pharmaceuticals Inc | 0.115M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.038M |
| Free Cash Flow | -8.92M |
| Free Cash Flow Per Share (Quarterly) | -1.604 |
| Free Cash Flow Yield | -715.1% |